Rixathon indications. Rixathon 500mg/50ml Infusion manufactured by Sandoz GmbH. 1 Non–Hodgkin’s Lymphoma (NHL) Rituxan (rituximab) is indicated for the treatment of patients with: Oct 6, 2025 · Rixathon monotherapy is indicated for treatment of adult patients with stage III-IV follicular lymphoma who are chemoresistant or are in their second or subsequent relapse after chemotherapy. Aug 14, 2025 · Rixathon 100 mg concentrate for solution for infusion - Summary of Product Characteristics (SmPC) by Sandoz Limited Rituximab is indicated in adults for the following indications: Non-Hodgkin's lymphoma (NHL): Rituximab is indicated for the treatment of previously untreated adult patients with stage III-IV follicular lymphoma in combination with chemotherapy. The reference medicine for Rixathon is MabThera. The safety and efficacy of rituximab paediatric patients > 6 months to < 18 years of age has not been established in indications other than previously untreated advanced stage CD20 positive DLBCL/BL/BAL/BLL. Rixathon (rituximab) is a monoclonal antibody that has revolutionized the treatment of certain types of cancer and autoimmune diseases. Feb 22, 2023 · Rixathon is typically administered by infusion, and the vial contains the concentrated liquid form of the medication. 1 INDICATIONS AND USAGE 1. Compare prices for generic rixathon substitutes: Reditux, REDITUX RA, REDITUX-RA. Your doctor, pharmacist or nurse should give you a copy of the Rixathon® Patient Alert Card every time you have a Rixathon® infusion. ugbdj fafwudx zidoac ewpc lkwgk xvg ebvtj vrngpqzqy kpon utwlg